Peter Sonsini, Ten Percent Owner at Arca Biopharma, holds 6.52M shares in Eargo (Ticker: EAR), holds 3.06M shares in Metacrine (Ticker: MTCR), holds 5.96M shares in Mersana Therapeutics (Ticker: MRSN).
Peter Sonsini latest transaction was an Uninformative Buy of ―.
What was Peter Sonsini's most profitable transaction?
Peter Sonsini’s most profitable transaction was an Informative Buy of AKAOQ stock on June 7, 2016. The return on the trade was 423.70%.
What is Peter Sonsini's role in Arca Biopharma?
Peter Sonsini's role in Arca Biopharma is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.